Andrew Slade
Impact in
- Virology top 10%
- HIV Research and Treatment
-
- PARP inhibition in cancer therapy
- Cancer-related Molecular Pathways
Papers in
-
- CRISPR and Genetic Engineering 3
- Cancer therapeutics and mechanisms 2
- DNA Repair Mechanisms 2
- Genetics 7
- Virus-based gene therapy research 7
- Co-authors
- Peter C. Terry (1 shared paper)Nicola J. Curtin (2 shared papers)Caroline J. Richardson (2 shared papers)David R. Newell (2 shared papers)Niall M.B. Martin (2 shared papers)Yan Zhao (2 shared papers)Michael A. Batey (2 shared papers)Suzanne Kyle (1 shared paper)
- Journals
- AIDS Research and Human Retroviruses (4 papers)Molecular Cancer Therapeutics (2 papers)Human Gene Therapy (1 paper)Clinical Cancer Research (1 paper)European Journal of Biochemistry (1 paper)
- Partner nations
- United KingdomCanadaSpain
In The Last Decade
Andrew Slade
17 papers receiving 551 citations
Peers
Comparison fields: 5 of 77
- Virology 62
- Oncology 191
- Biotechnology 53
- Molecular Biology 357
- Genetics 136
Countries citing papers authored by Andrew Slade
This map shows the geographic impact of Andrew Slade's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Slade with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Slade more than expected).
Fields of papers citing papers by Andrew Slade
This network shows the impact of papers produced by Andrew Slade. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Slade. The network helps show where Andrew Slade may publish in the future.
Co-authors
The 25 scholars most cited alongside Andrew Slade, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 113 | |
| 2 | 2012 | 99 | |
| 3 | 1995 | 77 | |
| 4 | 2005 | 74 | |
| 5 | 1992 | 47 | |
| 6 | 2001 | 40 | |
| 7 | 1991 | 32 | |
| 8 | 2000 | 28 | |
| 9 | 2008 | 20 | |
| 10 | 1991 | 19 | |
| 11 | 1993 | 7 | |
| 12 | 1997 | 6 | |
| 13 | 1995 | 5 | |
| 14 | 1995 | 5 | |
| 15 | 2004 | 4 | |
| 16 | 1999 | 1 | |
| 17 | Emerging platform bioprocesses for viral vectors and gene therapies | 2016 | 1 |
About Andrew Slade
Andrew Slade is a scholar working on Molecular Biology, Genetics, Virology, Oncology and Infectious Diseases, having authored 17 papers that have together received 578 indexed citations. Recurring topics across this work include Virus-based gene therapy research (7 papers), HIV Research and Treatment (5 papers), CRISPR and Genetic Engineering (3 papers), HIV/AIDS drug development and treatment (3 papers), Cancer therapeutics and mechanisms (2 papers), Amino Acid Enzymes and Metabolism (2 papers), DNA Repair Mechanisms (2 papers) and Herpesvirus Infections and Treatments (2 papers). The work is most often cited by research in Virology (62 citations), Oncology (191 citations), Biotechnology (53 citations), Molecular Biology (357 citations) and Genetics (136 citations). Andrew Slade has collaborated with scholars based in United Kingdom, Canada and Spain. Frequent co-authors include Peter C. Terry, Nicola J. Curtin, Caroline J. Richardson, David R. Newell, Niall M.B. Martin, Yan Zhao, Michael A. Batey, Suzanne Kyle, Alan Lau and Neil Almond. Their work appears in journals such as AIDS Research and Human Retroviruses, Molecular Cancer Therapeutics, Human Gene Therapy, Clinical Cancer Research and European Journal of Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.